Evidence of Relationships Between NAT2 and sulfasalazine
From Publications
| Relationship | Evidence | Details |
|---|---|---|
|
Phenotyping with sulfasalazine - time dependence and relation to NAT2 pharmacogenetics. International journal of clinical pharmacology and therapeutics. 2010. Kuhn U D, et al. PMID: 20040334. | View |
|
Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans. Clin Pharmacol Ther. 2008. Yamasaki Y, et al. PMID: 18167504. | View |
|
Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice. Pharmacogenet Genomics. 2007. Taniguchi Atsuo, et al. PMID: 17502830. | View |
PharmGKB® is a registered trademark of HHS and is
financially supported by NIH/NIGMS.
It is managed at Stanford University (GM61374).
©2001-2010 PharmGKB.
©2001-2010 PharmGKB.